Results 111 to 120 of about 6,841 (195)

The efficacy of tamsulosin 0.4 mg when tamsulosin 0.2 mg is insufficient for benign prostatic hyperplasia in Korean patients. [PDF]

Investig Clin Urol
Chung Y, Jeong SJ, Song SH, Hong SK.
europepmc   +1 more source

A fixed dose combination of tamsulosin and tadalafil in men with benign prostatic hyperplasia and erectile dysfunction: a prospective, multicenter, phase IV study. [PDF]

World J Urol
Gupta C, S AT, Pawar DS, Khandekar A, Deshmukh GR, Kumar V, Ramesh AV, Hemantkumar SI, Balkrishna PS, Rajurkar M, Sonawane D, Patil D, Ghadge P, Mehta S.   +13 more
europepmc   +1 more source

Quantum Biochemistry Insights into Ligand Recognition at the a_1A-Adrenoceptor. [PDF]

ACS Omega
Talinne da Costa Gomes L, Bezerra KS, Gavioli EC, Nobre Oliveira JI, Galvão DS, Fulco UL, Dantas da Silva Junior E.   +6 more
europepmc   +1 more source

Correlation between intravesical prostatic protrusion and ejaculatory dysfunction after tamsulosin treatment in men with BPH. [PDF]

World J Urol
Gezmiş CT, Çilesiz NC, Kartal VH, Altan MK, Çakıroğlu B, Balcı MBC.   +5 more
europepmc   +1 more source

Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]

Transl Androl Urol
Bakhsh A, Rajih E, Barayan GA, Garah E, Khan I, Alrehaili Z, Alhejaili S, Almuways M, Aloufi T, Alnazawi H, Alharbi A, Farghal D, Badawi A.   +12 more
europepmc   +1 more source

Doxazosin versus tamsulosin for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic literature review and network meta-analysis. [PDF]

World J Urol
Oelke M, Cornu JN, Chopra I, Herrmann TRW, Hassan T.   +4 more
europepmc   +1 more source

Outcome of medical treatments combined with tamsulosin for feline ureteral obstruction. [PDF]

J Vet Med Sci
Furusawa Y, Sogawa T, Kuramoto T, Ito S, Smith H, Fujiki M, Yabuki A.   +6 more
europepmc   +1 more source

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]

Medicina (Kaunas)
Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I.   +4 more
europepmc   +1 more source

Successful Treatment of Obstructive Ureterolithiasis with Medical Expulsive Therapy Including Tamsulosin in a Dog. [PDF]

Vet Sci
Park C, Lee Y, Chae Y, Yun T, Kang BT, Kim H.   +5 more
europepmc   +1 more source

Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Tu H, Ju C, McGurnaghan SJ, Blackbourn LAK, Scottish Diabetes Research Network Epidemiology Group, Pearson E, Wei L, Andrew R.   +7 more
europepmc   +1 more source